There was a rise in pharmaceutical companies, medical devices and digital treatments that invest in health care. Upscripthealth is one of the technology and applied services institutions that meet these companies.
Upscripthealth has more than 100 of these deals in its pipeline, PEER AX, founder and CEO of Virtual Care Company, with many matches that they already live including Pfizer, Dexcom, Axena Health, Spark Biomedical and Lucid Diagnostics. It works with pharmaceutical companies, medical devices and digital treatments to help people reach treatment through remote medical trees.
We talked to AX to discuss the factors that drive more pharmaceutical companies and medical devices to invest in health care. How to help health care from a distance Pharma improves access to rare and sophisticated diseases, and what the future looks like for a pharmacy vehicle that helps health care after, and how artificial intelligence enhances remotely when it comes to customizing treatment plans, monitoring the patient’s progress and identifying potential medical problems.
Q: What are the factors that drive more pharmaceutical companies and medical devices to invest in health care from a distance?
A. The increase we see in investing health care is primarily driven by the need to treat basic access barriers in our health care system. Patients often face waiting times for weeks and limited service providers, especially in the desert of pharmacy.
Critical administrative challenges, such as pre -maturity, also create problems with coverage in traditional health care settings that can simplify health care platforms effectively. Healthcare systems also allow more follow -up care, as it is often difficult to manage brick and mortar practices due to time restrictions.
We have seen how health care is treated from these challenges comprehensively by making health care easier during Removing traditional pain points in the health care system.
Q: How does health care help to improve access to rare and complex diseases?
A. We have seen the possibilities of health care from a distance that is greatly evolved from the relatively simple prescription to support treatments now for complex and rare diseases. Our recent partnership with Esoguard explains the examination of esophageal cancer this development by enabling doctors to evaluate the risk factors, describe the test and provide results through our digital platform.
In addition, we cooperated with Vive Health offers How can electronic health care cabinet revolution a revolution in providing treatmentAllow patients to receive blood tests with immediate results and arrange injections at alternative care sites. These innovations are the beginning of the extraordinary capabilities of Enehealth in direct care to patients for rare and complex diseases.
Q: How does the future seem to the pharmacy vehicle with a distance help?
A. The future of double pharmacies with the help of remote distance has a great promise. Health care can expand from the distance access to complex medicines, especially for patients in remote areas. It can also facilitate the reactions of the patient and the most frequent and personal doctor, which improves medicine management and commitment.
However, this integration requires careful study. Giving priority to patient safety is very important, which requires strong quality control measures within the guaranteed pharmacies and ensure that health care platforms are facilitated by comprehensive assessments of patients and continuous communication.
Q: How is artificial intelligence promoting health care when it comes to allocating treatment plans, monitoring the patient’s progress and identifying possible medical problems?
A. He was AI strategic implementation To enhance health care services from multiple contact points for the patient’s trip. Currently, we use artificial intelligence in the background to improve the questionnaires offered to patients when they enter the platform.
It is only traditionally prepared by doctors, but now we benefit from artificial intelligence to formulate more easy -to -use questions that are then reviewed by our medical professionals, ensuring access and clinical accuracy. We also use artificial intelligence in our Chatbots and our digital interfaces, making the patient’s reactions easier and responding to simplifying our statute development processes.
Looking at the future, we imagine the expansion of artificial intelligence applications to analyze the health data of the population and demographic patterns, allowing us to predict the patient’s individual needs of the extended time frames.
This predictive ability can help us to expect the patient’s health care requirements over the next decade of their lives, which ultimately provides more specialized and pre -emptive care through a remote health care platform.
Follow Bill Hit coverage on LinkedIn: Bill Seuiki
Email him: bsiwicki@himss.org
Information technology healthcare is a HIMSS media publication
